Concert Pharmaceuticals, Inc.
METHODS OF TREATMENT WITH DEUTERATED ANALOGS OF D-SERINE
Last updated:
Abstract:
This disclosure relates to deuterated D-serine, pharmaceutically acceptable salts thereof, analogs and prodrugs thereof, pharmaceutical compositions thereof, and methods of use.
Status:
Application
Type:
Utility
Filling date:
29 May 2020
Issue date:
14 Jul 2022